Clinical Updates

CKM Syndrome Staging: The First Multi-Society AHA/ACC/ADA/ASN Guideline, June 2026

CKM Syndrome Staging: What the First-Ever AHA/ACC/ADA/ASN Guideline Means for Primary Care

By Dr. Anush S. Pillai, DO, FAAFP | Reviewed by CME Travel Academy Faculty 7 min read  ·  Reviewed August 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference On June 9, 2026, the American Heart Association, American College of Cardiology, American Diabetes […]

CKM Syndrome Staging: What the First-Ever AHA/ACC/ADA/ASN Guideline Means for Primary Care Read More »

CME Travel Academy clinical update graphic: oral GLP-1 treatment for obesity, orforglipron, SELECT trial, 20% MACE risk reduction, 11.2% weight loss, 12 CME hours

Oral GLP-1 Treatment for Obesity: Orforglipron, the SELECT Trial, and the New 2026 Primary Care Playbook

By Dr. Vimal George, MD | Reviewed by CME Travel Academy Faculty8 min read  ·  Reviewed July 2026 Accredited CME: ✓ AMA PRA Category 1 Credit™ ✓ AAFP Prescribed ✓ AOA Category 2 ✓ 12 Credits per Conference In this article: Obesity Is Now a Cardiovascular Diagnosis Orforglipron Changes the Access Equation Injectable Incretins Still

Oral GLP-1 Treatment for Obesity: Orforglipron, the SELECT Trial, and the New 2026 Primary Care Playbook Read More »

Clinical update: 2025 AHA/ACC Hypertension Guidelines for Primary Care

2025 AHA/ACC Hypertension Guidelines: What Every Primary Care Clinician Must Know

For the first time in eight years, the American Heart Association (AHA) and the American College of Cardiology (ACC) have released a comprehensive overhaul of their hypertension guidelines. The 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults arrives at a critical moment: hypertension remains the single most

2025 AHA/ACC Hypertension Guidelines: What Every Primary Care Clinician Must Know Read More »

GINA 2026 Asthma Update featured image with key stats: ICS-formoterol AIR, four new primary-care exacerbation flowcharts, depemokimab Q26-week dosing.

GINA 2026: What’s New in Asthma Management for Primary Care

The Global Initiative for Asthma (GINA) released its 2026 Strategy Report on May 5, 2026, and primary care is squarely in its crosshairs. Asthma affects roughly 25 million Americans, and the majority of routine management still happens in family medicine, internal medicine, and advanced-practice offices rather than in pulmonology subspecialty suites. The 2026 update reflects

GINA 2026: What’s New in Asthma Management for Primary Care Read More »